Welcome to our dedicated page for Zimmer Biomet news (Ticker: ZBH), a resource for investors and traders seeking the latest updates and insights on Zimmer Biomet stock.
Zimmer Biomet Holdings, Inc. (ZBH) is a global innovator in musculoskeletal healthcare, delivering advanced orthopedic solutions for nearly a century. This news hub provides investors and medical professionals with timely updates on product developments, regulatory milestones, and strategic initiatives shaping the future of surgical care.
Track critical updates including quarterly earnings, FDA clearances for robotic surgery systems, and partnerships advancing AI-driven orthopedic solutions. Our curated feed consolidates press releases about joint reconstruction technologies, trauma care innovations, and global market expansions to inform your analysis of this medtech leader.
Discover how Zimmer Biomet’s integration of digital surgery platforms with traditional orthopedic expertise continues to redefine patient outcomes. Bookmark this page for direct access to verified updates about ZBH’s clinical advancements, without promotional commentary or speculative content.
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) announced FDA 510(k) clearance for the ROSA® Partial Knee System, which enhances robotically-assisted partial knee replacement surgeries. This addition to Zimmer Biomet's ROSA Robotics platform aims to improve patient outcomes and surgical accuracy. The system leverages advanced imaging technology and intraoperative data collection, which can optimize surgery based on individual patient anatomy. With over 50% of the global partial knee market share, Zimmer Biomet continues to lead in musculoskeletal healthcare, emphasizing its commitment to innovative solutions.
Zimmer Biomet Holdings (ZBH) will host its first quarter earnings conference call on May 4, 2021, at 8:30 a.m. ET. An associated news release with financial results will be available earlier that day at 6:30 a.m. ET. The conference call can be accessed via Zimmer Biomet's Investor Relations website, with a digital recording available post-call until July 6, 2021. This call provides an opportunity for investors to evaluate the company's financial performance and future outlook.
Zimmer Biomet Holdings (NYSE: ZBH) launched the ZBEdge™ Connected Intelligence Suite, featuring advanced digital and robotic technologies aimed at enhancing patient outcomes. Key components include the ROSA® Robotics Platform, Signature™ ONE Surgical Planning, and mymobility® with Apple Watch®. This suite integrates pre-, intra-, and post-operative technologies, leveraging data for improved surgical insights. The initiative underscores Zimmer Biomet's commitment to optimizing the patient experience and empowering healthcare professionals through actionable data.
Zimmer Biomet Holdings, Inc. (ZBH) announced important changes in its Executive Leadership Team on March 31, 2021. Lori Winkler has been appointed as the Chief Human Resources Officer (CHRO), having previously served as Group Vice President of Human Resources. Sang Yi has been promoted to Group President for Asia Pacific, a role he has held since June 2015. Both appointments are aimed at strengthening the company's human resources and regional operations as part of its mission to improve patient care globally.
Zimmer Biomet Holdings has appointed Ivan Tornos as Chief Operating Officer, effective March 19, 2021. Tornos, who joined the company in November 2018, will oversee all global businesses and lead operations, clinical education, and R&D. He continues to lead the Americas and now adds the EMEA region to his responsibilities. The company also announced Didier Deltort's departure as President of EMEA, effective immediately, with a search underway for his replacement. Tornos brings extensive experience from Becton, Dickinson, and C.R. Bard.
Zimmer Biomet Holdings has announced a quarterly cash dividend of $0.24 per share for the first quarter of 2021. The dividend is payable on April 30, 2021, to stockholders of record by March 29, 2021. The company continues to lead in musculoskeletal healthcare, providing a range of products for orthopedic reconstruction, sports medicine, and more. With operations in over 25 countries, Zimmer Biomet aims to enhance patient care through innovative solutions.
Zimmer Biomet Holdings announced significant changes to its Board of Directors. Sreelakshmi Kolli, Chief Digital Officer at Align Technology, joins the board immediately. Larry C. Glasscock, the Non-Executive Chairman, will retire in May 2021 as per governance guidelines. Following his retirement, Bryan C. Hanson, the current President and CEO, will assume the role of Chairman. Christopher B. Begley will become the Lead Independent Director. Additionally, Gail K. Boudreaux has opted not to seek reelection at the upcoming annual meeting. These changes reflect Zimmer Biomet's ongoing strategic initiatives.
Zimmer Biomet Holdings (NYSE: ZBH) announced that President and CEO Bryan Hanson and CFO Suky Upadhyay will present at the Cowen 41st Annual Health Care Conference on March 4, 2021, at 11:10 a.m. ET. The presentation will be accessible via a live webcast on Zimmer Biomet's Investor Relations website and will be archived for replay.
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a leader in musculoskeletal healthcare, providing innovative orthopedic and surgical products worldwide.
Zimmer Biomet Holdings, Inc. has appointed Vafa Jamali as the CEO of NewCo, a spin-off company which will focus on the Spine and Dental sectors, expected to launch in mid-2022. Jamali brings over 25 years of medical device experience, previously holding leadership roles at Rockley Photonics and Medtronic, where he led a $3 billion revenue division. His expertise is anticipated to drive growth and investment strategies for NewCo. Bryan Hanson, the current CEO of Zimmer Biomet, expressed confidence in Jamali’s ability to lead the new venture successfully.
Zimmer Biomet (ZBH) announced that President and CEO Bryan Hanson, along with Executive Vice President and CFO Suky Upadhyay, will present at Citi's 2021 Healthcare Services Conference on February 24, 2021, at 10:45 a.m. ET. A live webcast can be accessed via their Investor Relations website, which will also archive the presentation for later viewing. Zimmer Biomet, headquartered in Warsaw, Indiana, is a key player in musculoskeletal healthcare, offering a wide range of medical products and solutions.
FAQ
What is the current stock price of Zimmer Biomet (ZBH)?
What is the market cap of Zimmer Biomet (ZBH)?
